Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery

A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 100 participants.

Also called NCT07890857

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07890857
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07890857. Randomized; double masking; primary purpose treatment. Start 2026-11-01 (anticipated); primary completion 2028-11-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Superficial Parasternal Block Combined With Rectus Sheath Block for Open Cardiac Surgery
Condition
Cardiac Valve Disease
Condition
Coronary Heart Disease
Intervention (Drug)
Parasternal and rectus sheath block, ropivacaine 0.25 %
Lead sponsor
Hôpital du Valais (class: other)
Collaborator
University of Lausanne Hospitals (class: other)

Record details

Record id
cardio:ct-nct07890857
Content hash
9f9b46d239f7e09763b3a88317237404e10627deabd8e3f64ab62d797ade802c